3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myeloid, Acute
44
Precursor Cell Lymphoblastic Leukemia-Lymphoma
32
Myelodysplastic Syndromes
25
Recurrence
18
Multiple Myeloma
17
Lymphoma, Non-Hodgkin
14
Lymphoma, B-Cell
14
Lymphoma
14
Leukemia, Lymphocytic, Chronic, B-Cell
13
Ovarian Neoplasms
12
Hematologic Neoplasms
12
Pancreatic Neoplasms
10
Melanoma
10
Leukemia
9
Hodgkin Disease
9
Burkitt Lymphoma
9
Stomach Neoplasms
8
Myeloproliferative Disorders
8
Lymphoma, Large B-Cell, Diffuse
8
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
8
Neoplasms
7
Leukemia, Biphenotypic, Acute
7
Colorectal Neoplasms
7
Triple Negative Breast Neoplasms
6
Neoplasm Metastasis
6
Lymphoma, Mantle-Cell
6
Lymphoma, Follicular
6
Leukemia, Myelomonocytic, Juvenile
6
Leukemia, Myelomonocytic, Chronic
6
Breast Neoplasms
6
Interventions
Magnetic Resonance Spectroscopy
6
Biopsy
6
X-Rays
5
Specimen Handling
5
Phantoms, Imaging
5
Nuclear Medicine Department, Hospital
4
Cisplatin
3
Carboplatin
3
tazemetostat
2
selpercatinib
2
larotrectinib
2
erdafitinib
2
entrectinib
2
ensartinib
2
cabozantinib
2
Topotecan
2
Temozolomide
2
Surveys and Questionnaires
2
Radiation
2
LY3023414
2
Gemcitabine
2
Etoposide
2
Cyclophosphamide
2
ulixertinib
1
tipifarnib
1
pegfilgrastim
1
palbociclib
1
olaparib
1
niraparib
1
mirdametinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Central Nervous System Neoplasms
×
fludarabine
×
90 days
×
Clear all
No trials found.